These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 11266032)

  • 21. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
    Angelini A; Cappuccilli ML; Magnoni G; Croci Chiocchini AL; Aiello V; Napoletano A; Iacovella F; Troiano A; Mancini R; Capelli I; Cianciolo G
    G Ital Nefrol; 2021 Aug; 38(4):. PubMed ID: 34469084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients.
    Herrmann W; Obeid R
    Clin Chem Lab Med; 2005; 43(10):1039-47. PubMed ID: 16197295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial.
    Spence JD
    Clin Chem Lab Med; 2007; 45(12):1582-5. PubMed ID: 17937609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients.
    Sunder-Plassmann G; Hörl WH
    Hemodial Int; 2001 Jan; 5(1):86-91. PubMed ID: 28452434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing plasma total homocysteine in patients with end-stage renal disease.
    Urquhart BL; House AA
    Perit Dial Int; 2007; 27(5):476-88. PubMed ID: 17704433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: Renal failure, homocysteine and the pharmacology of vitamin B12.
    Hoffer LJ
    Metabolism; 2002 Apr; 51(4):399-402. PubMed ID: 11912543
    [No Abstract]   [Full Text] [Related]  

  • 27. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN; Mamer OA; Hoffer LJ
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of hyperhomocysteinemia in end-stage renal disease patients.
    Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G
    Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hyperhomocysteinemia in end-stage renal disease.
    Shemin D; Bostom AG; Selhub J
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S91-4. PubMed ID: 11576930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
    Capelli I; Cianciolo G; Gasperoni L; Zappulo F; Tondolo F; Cappuccilli M; La Manna G
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic B-vitamin therapy for hyperhomocysteinemia in dialysis patients: has the time come?
    Friedman AN
    Nutr Clin Care; 2002; 5(1):20-4. PubMed ID: 12134715
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.